Publications

Show Filters

Searches all publications.

Search Term

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-07-21
    E.g., 2018-07-21

Articles

257848 items
12:00 AM, May 17, 1993  |  BC Week In Review | Company News  |  Deals

Cryo-Cell deal

Cryo-Cell International Inc.   Cryo-Cell International Inc. has entered into an agreement with the University of Arizona to use cryopreserved stem cells, genes or other specimens for the treatment of altered or damaged immune systems. The...
12:00 AM, May 17, 1993  |  BC Week In Review | Company News  |  Deals

Glycomed Inc. deal

Glycomed Inc. (GLYC)   Glycomed Inc. (GLYC) has signed a three-year Cooperative Research and Development Agreement with the Lawrence Berkeley Laboratory (LBL) of the University of California to study the creation of chemical compounds for the...
12:00 AM, May 17, 1993  |  BC Week In Review | Company News  |  Deals

Biospherics Inc deal

Biospherics Inc. (BINC)   Biospherics Inc. (BINC) entered into an evaluation, development and marketing agreement with Valent U.S.A Corp. for BINC's natural carbohydrate pesticide. Valent, a wholly owned U.S. subsidiary of Sumitomo Chemical Co. Ltd., told...
12:00 AM, May 17, 1993  |  BC Week In Review | Company News  |  Deals

SangStat Medical Corp deal

The Pra-Stat test determines the level and types of antibodies of potential organ recipients; Cross-Stat matches antibodies between an organ and potential recipients and Typ-Stat determines the antigens of potential recipients and donors. SangStat's HLA...
12:00 AM, May 17, 1993  |  BC Week In Review | Company News  |  Deals

Collagen Corp., Collagen Corp. deal

Collagen Corp. (CGEN) and privately held GenPharm International Inc. are collaborating to develop human collagen from the milk of transgenic dairy cattle. The process entails the microinjection of the human gene into a cow egg,...
12:00 AM, May 17, 1993  |  BC Week In Review | Company News  |  Deals

U.S. Bioscience deal

Schering-Plough will pay UBS an up-front licensing fee and milestone payments that together could total up to $10 million. UBS also will receive a share of Schering-Plough's operating profits from sales. After assuming sole marketing...
12:00 AM, May 17, 1993  |  BC Week In Review | Company News  |  Deals

Stratagene deal

Stratagene   Separately, GenPharm and Stratagene have developed a transgenic mouse for mutagenesis and tumorigenesis research. The mouse, which is a cross between GenPharm's TSG-p53 transgenic mouse and Stratagene's Big Blue transgenic mouse, will...
12:00 AM, May 17, 1993  |  BC Week In Review | Company News  |  Deals

MGI deal

MGI Pharma Inc. (MOGN)   MGI Pharma Inc. (MOGN) has acquired the patent rights to anti-estrogenic cancer agents from Research Corporation Technologies. The tumor growth blockers, which will be studied for use in breast cancer therapeutics,...
12:00 AM, May 17, 1993  |  BC Week In Review | Clinical News  |  Clinical Status

RIGScan radiolabeled antibody: Phase III trial started

Also in Phase III for primary colorectal cancer Neoprobe Corp. (NEOP)   Product: RIGScan radiolabeled antibody   Indication: Metastatic colorectal cancer   Status: Phase III trial to start within 60 days   ...
12:00 AM, May 17, 1993  |  BC Week In Review | Clinical News  |  Clinical Status

BetaKine TGF-beta-2: Began a 90-patient Phase II study

Celtrix Pharmaceuticals Inc. (CTRX)   Product: BetaKine TGF-beta-2   Indication: Slow or halt the progression of "wet" or exudative age-related macular degeneration   Status: Began a 90-patient Phase II study   ...

Pages